John C. Fortson - 10 Aug 2026 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Reporting relationship: EVP & CFO
Issuer ticker: XRAY
Reported as of: 10 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Aug 2026, 16:25:41 UTC
Prior SEC filing: 21 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Jessica Nielsen Causey, Attorney-In-Fact for John C. Fortson

Key filing fact

John C. Fortson filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 12 Aug 2026.

Key facts

This page summarizes John C. Fortson's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Aug 2026, 16:25.

Change

Previous filing in this sequence was filed on 21 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001582539 Primary reporting owner

Fortson John C.

Relationship: EVP & CFO
Address: C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE
Signature: /s/ Jessica Nielsen Causey, Attorney-In-Fact for John C. Fortson
Signature date: 12 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRAY transaction

Common Stock

Award

Transaction value
Shares: +24,014
Change %
Price: $0.000000^*
Shares after: 24,014
Date: 10 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XRAY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +104,200
Change %
Price: $0.000000^*
Shares after: 104,200
Date: 10 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 104,200
Exercise price: $12.83
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending August 10, 2029.

Footnote F2

Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending August 10, 2029, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.